Felix Beuschlein
LightNews LightNews
banner
fbeuschlein.bsky.social
Felix Beuschlein
@fbeuschlein.bsky.social
430 followers 300 following 95 posts
Endocrinologist, adrenal researcher, EiC of European Journal of Endocrinology, gardener, art & science enthusiast
Posts Replies Media Videos
Reposted by Felix Beuschlein
adinaturcu.bsky.social
Congrats to 3 adrenal stars: Martin, Maria-Christina, and Tracy!! 👏👏👏
October 29, 2025 at 3:55 PM
Reposted by Felix Beuschlein
esendocrinology.bsky.social
We are delighted to announce the winners of the ESE Awards for 2026.🏆

🎉Congratulations to our exceptional winners who have made huge contributions in the field of #endocrinology and will present at #ECE2026 in Prague, Czech Republic from 9-12 May 2026.

Find out more👉 ow.ly/ITyL50XjEWm
October 29, 2025 at 2:00 PM
Reposted by Felix Beuschlein
esendocrinology.bsky.social
The publication of the EndoCompass Research Roadmap marks a major milestone for endocrine science. It was a real community effort, involving:

🧠 228 experts
💡 10 specialist partners
🙋‍♀️ 8 patient advocacy groups

Thank you to everyone who contributed!

academic.oup.com/ejendo/issue/193/Supplement_2
October 28, 2025 at 4:09 PM
Reposted by Felix Beuschlein
wiebkearlt.bsky.social
4 previous ESE presidents and the current president of ESE @esendocrinology.bsky.social plotting with ESE-EYES early career group lead and the fabulous ESE team - exciting things to come at ECE 2026 where we will have a super fun interactive session on 20 years of ESE!!
October 23, 2025 at 2:51 PM
Reposted by Felix Beuschlein
eurojendo.bsky.social
INVITED REVIEW The evolving landscape of Thyroid Eye Disease: present and future by David Toro-Tobon and Marius N Stan @mayoclinic.org

EJE Volume 193, Issue 2, August 2025
👉 doi.org/10.1093/ejen...
ESE Members free via 👉 my.ese-hormones.org

#endocrinology #thyroid
The evolving landscape of thyroid eye disease: present and future
Abstract. Thyroid eye disease (TED) is a complex ocular autoimmune disorder primarily associated with Graves’ disease. It leads to significant morbidity du
doi.org
October 16, 2025 at 11:36 AM
fbeuschlein.bsky.social
Oberbozen, Italy
October 14, 2025 at 6:03 AM
Reposted by Felix Beuschlein
esendocrinology.bsky.social
Following the ESE Executive Committee meeting in Munich last week, members of the ESE leadership team were delighted to be invited to the retirement lecture for Martin Reincke, Past-President of ESE, at @lmumuenchen.bsky.social. We wish Martin all the best in his next chapter.
#OurEndocrineCommunity
October 13, 2025 at 3:35 PM
fbeuschlein.bsky.social
Congratulations to the whole team!
jeromebertherat.bsky.social Jérôme Bertherat @jeromebertherat.bsky.social · Oct 6
Pleased to see our Nature Com free to download paper : Single cell atlas of adrenal tumors revealing a transition state in the centripetal trans-differentiation of nor-
mal steroid cells and specific microenvironment ecotypes
associated with survival of adrenal cancer 👇👇👇

rdcu.be/eJIE4
October 6, 2025 at 5:07 PM
Reposted by Felix Beuschlein
colinschultz.bsky.social
That one atheist is _really_ confused
conradhackett.bsky.social Conrad Hackett @conradhackett.bsky.social · Sep 27
When asked if Jesus “will return to Earth someday,” more than half of all U.S. adults (55%), including three-quarters of Christians, said this will happen.
www.pewresearch.org/short-reads/...
When asked if Jesus “will return to Earth someday,” more than half of all U.S. adults (55%), including three-quarters of Christians, say this will happen. Protestants in the evangelical (92%) and historically Black (86%) traditions are more likely than other Christians to say there will eventually be a second coming of Jesus. Roughly four-in-ten Americans either do not believe Jesus will return to Earth (25%) or say they do not believe in Jesus (16%). Respondents who said they believe Jesus will return to Earth were also asked how certain they are that this will happen during their lifetime. One-in-ten Americans say they believe the second coming of Jesus will definitely or probably occur during their lifetime, 27% are not sure if Jesus will return in their lifetime, and 19% say the return of Jesus will definitely or probably not occur during their lifetime. The proportion of Americans who say they believe Jesus will definitely or probably return during their lifetime is higher among Protestants in the historically Black tradition (22%) and evangelical Protestants (21%), and lower among Catholics (7%) and mainline Protestants (6%). And the share of Black (19%) and Hispanic (14%) Americans who believe that the second coming of Jesus will likely occur during their lifetime is greater than the corresponding share of White, non-Hispanic Americans (8%).
September 29, 2025 at 5:32 AM
Reposted by Felix Beuschlein
eurojendo.bsky.social
Disrupted ACTH and Cortisol Response to Osmotic and Non-Osmotic Stress in Patients with AVP-Deficiency by Andi Nikaj et al

EJE Volume 193, Issue 1, July 2025
Open access article 👉 doi.org/10.1093/ejen...

#AVPdeficiency #pituitary #arginine #vasopressin #oxytocin #hypothalamus
September 29, 2025 at 9:27 AM
Reposted by Felix Beuschlein
a5-adrenal.bsky.social
Thank you to the chairs (Isabelle Bourdeau, Andre Lacroix, Karel Pacak) for a great #ISP2025. #pheo #para #ENSAT #A5 and more
September 24, 2025 at 1:13 PM
fbeuschlein.bsky.social
For once better than „Solar panel“
natesmith.dev Nate's Myth @natesmith.dev · Sep 11
Gasoline would be such a beautiful name for a girl (rhymes w Caroline)
September 12, 2025 at 1:24 PM
Reposted by Felix Beuschlein
cronchi.bsky.social
Impressions from the joint final EU Cost Action Harmonisation conference & 24th #ENSAT2025 annual meeting in Belgrade! It has been a great success with 230 participants from all over the world. Huge thanks to LOC chair @ljiljanamarina.bsky.social and team, and all the ENS@T ExCo for excellent job.
September 7, 2025 at 5:38 AM
Reposted by Felix Beuschlein
eurojendo.bsky.social
NEW RESEARCH Expert Consensus on the Primary Aldosteronism Severity Classification (EC-PASC) and its Strategic Application in Indicating Adrenal Venous Sampling by Masanori Murakami et al

👉 doi.org/10.1093/ejen...
ESE members free via 👉 my.ese-hormones.org
September 3, 2025 at 9:43 AM
Reposted by Felix Beuschlein
zimmermanv66.bsky.social
September 1, 2025 at 8:59 AM
Reposted by Felix Beuschlein
architecture.bsky.social
Tij—an egg-shaped bird observatory designed by RAU & Ro&Ad Architecten —was built in the Haringvliet area, Netherlands, to allow people to experience the ecological impact of the sluice openings.
Tij—an egg-shaped bird observatory Tij—an egg-shaped bird observatory Tij—an egg-shaped bird observatory Tij—an egg-shaped bird observatory
August 29, 2025 at 12:06 PM
Reposted by Felix Beuschlein
esendocrinology.bsky.social
Is the endocrine workforce fit for purpose?

The State of #Endocrinology survey is a major new project to address the significant challenges our field is facing.

Make sure your country is represented!

👉 Take the survey today: www.research.net/r/State_of_E...
August 28, 2025 at 1:49 PM
Reposted by Felix Beuschlein
ethz.ch
A research team from ETH Zurich has taught the four-legged robot Hashtag#ANYmal to play Hashtag#badminton – including precise arm movements, quick reflexes and nimble footwork.
August 25, 2025 at 12:05 PM
Reposted by Felix Beuschlein
esendocrinology.bsky.social
The State of Endocrinology survey aims to be a ‘fitness test’ for the clinical and research dimensions of endocrinology.

The outcomes of the survey will underpin ESE’s and your National Society’s advocacy efforts towards healthcare decision makers. Act now! 👇🚨
www.research.net/r/State_of_E...
August 17, 2025 at 4:22 PM
Reposted by Felix Beuschlein
ucs.org
Calling all scientists and science supporters! You have a crucial role to play in countering the authoritarian threat we currently face in this country. Learn more about how you can stand up for the facts and truth that are essential for a free and democratic society. blog.ucs.org/gretchen-gol...
August 14, 2025 at 9:05 PM
Reposted by Felix Beuschlein
danieljdrucker.bsky.social
A new tragedy for the Endocrine community An outstanding scientist leaves us too soon
August 4, 2025 at 6:15 PM
Reposted by Felix Beuschlein
eurojendo.bsky.social
Prevalence and clinical associations of #USP8 variants in corticotroph tumours: a systematic review and aggregate data meta-analysis of 2171 cases by Luis G Perez-Rivas et al

EJE Volume 192, Issue 6, June 2025
Open access 👉 doi.org/10.1093/ejen...

#Cushingsdisease
Prevalence and clinical associations of USP8 variants in corticotroph tumours: a systematic review and aggregate data meta-analysis of 2171 cases
AbstractObjective. Somatic USP8 variants are common in corticotroph tumours, but their reported prevalence and association with clinical characteristics va
doi.org
August 5, 2025 at 2:40 PM
Reposted by Felix Beuschlein
natureportfolio.nature.com
A technology feature in Nature describes how enzyme-based techniques and refinements in organic chemistry are easing the generation of extended DNA sequences. 🧬 🧪
Made-to-order DNA goes big: new tech doubles size of custom genetic sequences
Enzyme-based techniques and refinements in organic chemistry ease the generation of extended DNA sequences.
go.nature.com
July 28, 2025 at 4:16 AM
Reposted by Felix Beuschlein
feministscientist.bsky.social
Happy Birthday, Rosalind Franklin. She captured an X-ray diffraction image of DNA and stated that a helical structure was probable. Watson and Crick then created a detailed model based on her results. They initially received credit for the discovery and were awarded the Nobel Prize after her death.🧪
July 26, 2025 at 6:05 AM
fbeuschlein.bsky.social
Oh boy, more work for endocrinologist (explaining why this is not a good idea) to come
erictopol.bsky.social Eric Topol @erictopol.bsky.social · Jul 21
There's been a big surge of people getting injections of biologically active peptides without data to support their use or FDA approval (and off-label use). I've written about the status of 15 of them here, along with NAD+.
erictopol.substack.com/p/the-peptid...
The Peptide Craze
The Surge in Use of Off-Label and Non-FDA Approved Peptides
erictopol.substack.com
July 21, 2025 at 5:52 AM